Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a storytelling app boost Well-Being in older adults with memory loss?

NCT ID NCT07685067

Symptom relief Sponsor: George Mason University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests a mobile app called LifeBio Memory that helps older adults with mild cognitive impairment share their life stories using photos, voice recordings, and culturally tailored prompts. The app aims to improve quality of life, reduce depressive symptoms and loneliness, and strengthen bonds with caregivers. Researchers will enroll 168 participants (84 older adults and their caregivers) from diverse backgrounds to see if this non-drug approach supports emotional and cognitive well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
LifeBio Memory (LBM) digital reminiscence therapy app
What this could lead to
If effective, this app could offer a simple, non-drug way to improve emotional well-being and social connection for older adults with memory concerns.
What could go wrong
This is an early-stage study with a small, diverse sample. The app may not produce meaningful improvements, and results may not apply to all groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 168 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The investigators will enroll a total of 84 older adult participants and 84 informal caregivers across the 84 dyads, comprising 21 Hispanic/Latino dyads, 21 Korean dyads, 21 Black dyads, and 21 Non-Hispanic White dyads. The inclusion and exclusion criteria for older adult participants are: 1. Self-identified as Hispanic/Latino, Korean, Black/African American, and Non-Hispanic White 2. Speak and read Spanish, Korean, or English 3. Aged 60 years and older, with Montreal Cognitive Assessment (MoCA) test scores ranging 18-30 (with MCI: 18-25, or at risk for MCI: 26-30) 4. Have a local or in-home informal caregiver who can participate who is age 18 or older 5. No pre-existing acute psychotic disease or critical illness 6. Consent to participate The inclusion and exclusion criteria for informal caregivers are: 1. Self-identified as Hispanic/Latino, Korean, Black/African American, and Non-Hispanic White 2. Speak and read Spanish, Korean, or English 3. Aged 18 years and older 4. Currently serving as the primary informal caregiver for older adults aged 60 or older 5. No pre-existing acute psychotic disease or critical illness 6. Consent to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mild cognitive impairment are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mild cognitive impairment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.